What should be done with patients who have abnormal GCT but normal GTT?
dc.authorid | Yologlu, Saim/0000-0002-9619-3462 | |
dc.authorwosid | Yologlu, Saim/ABI-8014-2020 | |
dc.contributor.author | Kafkasli, A | |
dc.contributor.author | Karabulut, A | |
dc.contributor.author | Kazezoglu, G | |
dc.contributor.author | Kulak, N | |
dc.contributor.author | Koçak, M | |
dc.contributor.author | Yologlu, S | |
dc.date.accessioned | 2024-08-04T21:02:24Z | |
dc.date.available | 2024-08-04T21:02:24Z | |
dc.date.issued | 2004 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description | 19th European Congress of Perinatal Medicine -- OCT 14-16, 2004 -- Athens, GREECE | en_US |
dc.description.abstract | The aim of this study is to evaluate the carbonhydrate metabolism in pregnants with abnormal glucose challenge, but normal 100g-3-hour oral glucose tolerance test. Pregnants who were delivered at Ynonu University School of Medicine Department of Obstetrics and Gynecology and meet the criteria included the study. Group 1(n:6) gestational diabetes mellitus, Group 2(n: 8) Type 2 diabetes mellitus, Group 3(n: 10) plasma glucose levels were 140mg/dl f after glucose challenge test, but normal 100g-oral glucose tolerance test, Group 4(n:8) pregnants with normal glucose challenge test and have appropriate-for-gestational-age neonate as control group,Group 5(n:8) pregnants with normal glucose challenge test and have macrosomic neonate were included the study. Maternal blood was collected to evaluate the carbonhydrate metabolism by comparing the IGF-I,II and IGFBP-1,2,3 levels. IGF I-II and IGFBP1,2,3 measurements were done by RIA and IRMA technics respectively. Maternal plasma levels of IGF-II and IGFBP-1, -3 were found to be significantly higher than control group in gestational diabetics, type-2 diabetic pregnants, pregnants with abnormal glucose challenge test but normal 100g-oral tolerance test and pregnants with macrosomic infant (p<0.000, p<0.000, p<0.05, p<0.05). | en_US |
dc.description.sponsorship | European Assoc Perinatal Med | en_US |
dc.identifier.endpage | 280 | en_US |
dc.identifier.isbn | 88-7587-091-8 | |
dc.identifier.startpage | 275 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/104723 | |
dc.identifier.wos | WOS:000225154900045 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Medimond Publishing Co | en_US |
dc.relation.ispartof | Proceedings of The Xix European Congress of Perinatal Medicine | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Binding-Proteins | en_US |
dc.subject | Pregnancy | en_US |
dc.title | What should be done with patients who have abnormal GCT but normal GTT? | en_US |
dc.type | Conference Object | en_US |